Correlation Between Crinetics Pharmaceuticals and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Pfizer Inc, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Pfizer.

Diversification Opportunities for Crinetics Pharmaceuticals and Pfizer

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Crinetics and Pfizer is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Pfizer go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and Pfizer

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 1.39 times more return on investment than Pfizer. However, Crinetics Pharmaceuticals is 1.39 times more volatile than Pfizer Inc. It trades about 0.06 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.16 per unit of risk. If you would invest  5,596  in Crinetics Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  124.00  from holding Crinetics Pharmaceuticals or generate 2.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Crinetics Pharmaceuticals  vs.  Pfizer Inc

 Performance 
       Timeline  
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Crinetics Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Crinetics Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Crinetics Pharmaceuticals and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crinetics Pharmaceuticals and Pfizer

The main advantage of trading using opposite Crinetics Pharmaceuticals and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Crinetics Pharmaceuticals and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments